Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)
318.00
+1.00 (0.32%)
Jan 21, 2026, 3:30 PM JST
Wakamoto Pharmaceutical Company Description
Wakamoto Pharmaceutical Co.,Ltd. engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan.
The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug.
It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste.
The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943.
Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
Wakamoto Pharmaceutical Co.,Ltd.
| Country | Japan |
| Founded | 1929 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 403 |
| CEO | Arata Igarashi |
Contact Details
Address: 2-2-2, Nihonbashi Honcho Tokyo, 103-8330 Japan | |
| Phone | 81 3 3297 0371 |
| Website | wakamoto-pharm.co.jp |
Stock Details
| Ticker Symbol | 4512 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3991200001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Arata Igarashi | Chief Executive Officer |